-
Dr Reddy’s launches Succinylcholine Chloride Injection in US
expresspharma
November 16, 2020
It is a sterile, nonpyrogenic solution to be used as an ultra-short acting, depolarizing, skeletal muscle relaxant.
-
NATCO gets US FDA approval for Pomalidomide capsules
expresspharma
November 16, 2020
Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical, has received final approval for its Abbreviated New Drug Application (ANDA) for Pomalidomide Capsules, from the US Food and Drug Administration {USFDA).
-
Israel to enter into a deal with Pfizer for COVID-19 vaccine
expresspharma
November 16, 2020
The supply would begin in January 2021, with the remainder arriving throughout the course of 2021: Israel’s Health Minister.
-
FDA grants emergency use authorisation to COVID-19 antibody bamlanivimab
europeanpharmaceuticalreview
November 13, 2020
The neutralising antibody therapy bamlanivimab (LY-CoV555) is authorised for emergency use in recently diagnosed patients who are at risk of developing severe COVID-19.
-
FDA grants Fast Track Designation to Novavax COVID-19 vaccine candidate
europeanpharmaceuticalreview
November 13, 2020
The FDA has given Fast Track Designation to NVX-CoV2373, Novavax’s COVID-19 vaccine candidate, created using recombinant nanoparticle technology.
-
Amneal gets US FDA approval for Acyclovir Cream
expresspharma
November 13, 2020
It is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older.
-
Lupin’s alliance partner Concord gets USFDA nod for Tacrolimus Capsules
expresspharma
November 13, 2020
They are indicated for prophylaxis of organ rejection in adult and paediatric patients receiving allogeneic liver, kidney or heart transplants.
-
Sedor Pharmaceuticals gets FDA approval for SESQUIENT to treat status epilepticus
pharmaceutical-business-review
November 12, 2020
Sedor Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved SESQUIENT (fosphenytoin sodium for injection) for the treatment of status epilepticus in adult and pediatric patients.
-
FDA Approves Updated Label for Endari
americanpharmaceuticalreview
November 12, 2020
Emmaus Life Sciences has announced revised prescribing information for Endari® to better inform healthcare professionals and sickle cell disease patients.
-
Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA
worldpharmanews
November 11, 2020
Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.